NCR Drug, Medical Device Makers Can Use Gensets Freely

Mumbai : Manufacturers of medical devices, medical equipment and medicines can use diesel generator sets to run their production facilities irrespective of the curbs imposed by pollution control agencies in the National Capital Region (NCR) from time to time.

The Central government’s Commission for Air Quality Management in National Capital Region & Adjoining Areas has added these categories, along with medical services, as activities that are exempted from such restrictions.

The commission, in a directive on December 13, said activities or services categorised as emergency will be permitted to use diesel generator sets as an exception in NCR whenever orders for a ban are issued.

The commission’s recent directive for shutting down industrial units that use diesel generator sets in NCR as a temporary measure to bring down pollution levels in Delhi and adjoining areas had threatened to disrupt production of syringes and needles at India’s largest syringe maker located in Faridabad near Delhi. Though a clarification had allowed production of syringes, the latest directive has cleared the uncertainty regarding such curbs in future, increasing the attractiveness of NCR and adjoining areas as a medical device manufacturing location. Uttar Pradesh government, for instance, has been trying to develop a medical device park in Greater Noida.

The other category of activities and services that are permitted to use diesel generator sets include metro rail services, including trains and stations, airports, inter-state bus terminals, sewerage treatment plants, water pumping stations, national security and defence related installations, projects of national importance, elevators and escalators and railway services. The commission has asked all enforcement agencies like state pollution control boards to comply with its new directive.

  • Related Posts

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    PharmEasy, the online medical platform emphasizes the importance of early prevention and regular health screenings to reduce the risk of diabetes. By encouraging individuals to undergo timely blood sugar tests,…

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    India’s pharmaceutical exporters have been offered a fresh business opportunity to expand their presence in Saudi Arabia, with Riyadh-based Al Hobail Medical Company seeking Indian manufacturing partners for the registration…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

    UP expands food, drug testing capacity across all 18 divisions

    UP expands food, drug testing capacity across all 18 divisions

    Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

    Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

    Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi

    Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi